Neurocrine Bioscience buy Truist Financial Co.
Start price
30.10.25
/
50%
€119.35
Target price
30.10.26
€148.09
Performance (%)
30.00%
Price
27.07.26
€155.15
Summary
This prediction is currently active. The prediction currently has a performance of 30.00%. This prediction currently runs until 30.10.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 3.516% | 3.516% |
| iShares Core DAX® | 0.855% | 0.389% |
| iShares Nasdaq 100 | -0.989% | -4.400% |
| iShares Nikkei 225® | -1.781% | -11.216% |
| iShares S&P 500 | 0.057% | 0.778% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NASDAQ:NBIX) had its "buy" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $172.00 price target on the stock, up previously from $165.00.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€154.55
13.07.26
13.07.26
€175.50
13.07.27
13.07.27
0.39%
27.07.26
27.07.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€127.50
07.05.26
07.05.26
€131.84
07.05.27
07.05.27
21.69%
27.07.26
27.07.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
17.02.26
17.02.26
€118.20
17.02.27
17.02.27
43.86%
27.07.26
27.07.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€116.75
08.01.26
08.01.26
€144.77
08.01.27
08.01.27
32.89%
27.07.26
27.07.26